Dataset Information


Effect of Dexmedetomidine in Preventing Postoperative Side Effects for Laparoscopic Surgery: A Meta-Analysis of Randomized Controlled Trials and Trial Sequential Analysis (PRISMA).

ABSTRACT: Dexmedetomidine (DEX) has been used extensively for patients during surgery. Some studies found that DEX could reduce the incidence of postoperative side effects in laparoscopic surgical patients. However, no firm conclusions were made about it.The authors searched for randomized controlled trials (RCTs) in PubMed, EMBASE, and the Cochrane Central Register of Controlled Trials testing DEX administrated in laparoscopic surgical patients and reporting on postoperative nausea, vomiting, shivering, heart rate, mean arterial pressure (MAP), or extubation time after surgery or within 1 hour in postoperative care unit. Trial sequential analysis (TSA) was used for RCTs comparing DEX with placebo or no treatment in laparoscopic surgery patients. A protocol for this meta-analysis has been registered on PROSPERO (http://www.crd.york.ac.uk/prospero) and the registration number is CRD42015020226.Fifteen studies (899 patients) were included. DEX could significantly reduce the incidence of postoperative nausea (risk ratio [RR] and 95% confidence interval [CI], 0.43 [0.28, 0.66], P?


PROVIDER: S-EPMC4998870 | BioStudies | 2016-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC5681692 | BioStudies
2018-01-01 | S-EPMC5840390 | BioStudies
2019-01-01 | S-EPMC6538060 | BioStudies
1000-01-01 | S-EPMC5814442 | BioStudies
2013-01-01 | S-EPMC3862842 | BioStudies
2018-01-01 | S-EPMC5910570 | BioStudies
2020-01-01 | S-EPMC7448354 | BioStudies
2020-01-01 | S-EPMC7253658 | BioStudies
2019-01-01 | S-EPMC6873751 | BioStudies
2020-01-01 | S-EPMC7521726 | BioStudies